Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by
chronic ovulation dysfunction and overabundance of androgens; it affects 6–20% of women …

Cancer is still the leading cause of death worldwide, burdening the global medical system.
Rosmarinic acid (RA) is among the first secondary metabolites discovered and it is a …

Polycystic ovarian syndrome (PCOS) is the most common endocrine pathology in females of
reproductive age worldwide. The prevalence of PCOS varies between 6% and 13% based …

Cancer poses a significant global health challenge, with predictions of increasing
prevalence in the coming years due to limited prevention, late diagnosis, and inadequate …

Background/objectives In recent years, the reproductive toxicity of new bisphenol analogs
has garnered much interest, but it remains to be determined whether bisphenol analogs …

Oxidative stress represents the pathophysiological basis for most disorders, including
reproductive issues. Polycystic ovary syndrome (PCOS) is heterogeneous endocrine …

Cardiovascular diseases (CVD) have a lower prevalence in women than men; although, a
higher mortality rate and a poorer prognosis are more common in women. However, there is …

Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disease in
women of childbearing age and can cause metabolic disorder, infertility, and increased …

Aim: Polycystic ovary syndrome (PCOS) is an increasingly recognized endocrine disorder.
The pathogenesis is not fully known. Polycystic ovary syndrome is still difficult to diagnose …

The treatment of polycystic ovary syndrome (PCOS) faces challenges as all known
treatments are merely symptomatic. The US Food and Drug Administration has not approved …